Burkholderia cepacia complex in cystic fibrosis in a Brazilian reference center
- 30 September 2017
- journal article
- research article
- Published by Springer Nature in Medical Microbiology and Immunology
- Vol. 206 (6) , 447-461
Abstract
The Burkholderia cepacia complex (BCC) can cause a severe decline in lung function in cystic fibrosis (CF). Our objective was to determine the BCC prevalence and to evaluate its clinical impact on CF. Clinical and laboratory variables were determined for CF patients with BCC (Group-A = 50 patients) and without BCC (Group-B = 134 patients). The microorganisms were identified by biochemical tests, the Vitek2®Compact test, recA-PCR and recA-nested-PCR with species-specific primers and DNA sequencing. The patients were evaluated by the Shwachman–Kulczycki score (SKCS), Bhalla score (BS), spirometry and body mass index (BMI). The BCC prevalence was 22.5%. The most common species were Burkholderia multivorans (30%), Burkholderia cepacia (24%), Burkholderia cenocepacia IIIA (10%), B. cenocepacia IIIB (2%) and Burkholderia vietnamiensis (2%). There was difference between the groups in nutritional status (p = 0.02) and general activity (p = 0.026). There was difference in total BS points (p = 0.04) and the following parameters: bronchiectasis severity (p = 0.007), peribronchial thickening (p = 0.013), bronchiectasis extent (p = 0.01) and general aspects of the affected bronchial zone (p = 0.02). The respiratory disorder classifications were as follows: obstructive-4.8% (Group-A) and 23.8% (Group-B); restrictive-9.5% (Group-A and Group-B); obstructive + restrictive-19% (Group-A) and 1.6% (Group-B); and obstructive + restrictive with a decreased forced expiratory flow-47.6% (Group-A) and 30.2% (Group-B) (p = 0.02). Nutritional status was a minor contributing factor to weight, height and BMI in the Group-A (p = 0.02). The BCC prevalence, particularly the prevalence of B. multivorans, was higher in this study. The SKCS, BS, spirometry and nutritional status results showed that BCC has a negative impact on clinical status. Phenotypic methods are useful for the identification of presumptive BCC. The Vitek2®Compact test showed accuracy in BCC identification. PCR, nested-PCR, and recA sequencing showed specificity in BCC species identification.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2011/12939-4, 2015/12858-5, 2011/18845-1, 2015/12183-8)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (BR) (2015/12183-8)
- Fundo de Apoio à Pesquisa ao Ensino e à Extensão da Universidade Estadual de Campinas (648/2015)
This publication has 65 references indexed in Scilit:
- Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.International Journal of Systematic and Evolutionary Microbiology, 2009
- Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment centerEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Exceptionally High Representation of Burkholderia cepacia among B. cepacia Complex Isolates Recovered from the Major Portuguese Cystic Fibrosis CenterJournal of Clinical Microbiology, 2007
- Molecular epidemiology and antibiotic susceptibility of Burkholderia cepacia-complex isolates from an Italian cystic fibrosis centreEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Prevalência de bactérias potencialmente patogênicas em espécimes respiratórios de fibrocísticos do RecifeJornal Brasileiro de Patologia e Medicina Laboratorial, 2004
- Análise crítica dos escores de avaliação de gravidade da fibrose cística: estado da arteJornal Brasileiro de Pneumologia, 2004
- Epidemiology and Clinical Course of Burkholderia cepacia Complex Infections, Particularly Those Caused by Different Burkholderia cenocepacia Strains, among Patients Attending an Italian Cystic Fibrosis CenterJournal of Clinical Microbiology, 2004
- Pseudomonas cepacia infection in cystic fibrosis: An emerging problemThe Journal of Pediatrics, 1984
- A new prognostic score and clinical evaluation system for cystic fibrosisThe Journal of Pediatrics, 1973
- A 5 year clinical evaluation of a therapeutic program for patients with cystic fibrosisThe Journal of Pediatrics, 1964